Medicine News and Research

RSS

UVA scientists develop AI tools to accelerate new drug discovery

University of Virginia School of Medicine scientists have developed a bold new approach to drug development and discovery that could dramatically accelerate the creation of new medicines.

9 Apr 2026

Study shows long-term weight benefits for breastfeeding mothers

Breastfeeding does not only affect your weight while you are breastfeeding. Women gain up to 6.5 kilos less on average later in life if they breastfeed for at least three months, according to a new study.

9 Apr 2026

Fat-producing enzyme identified as key driver of damage in Parkinson’s disease

A fat-producing enzyme in brain cells may play a key role in driving damage in Parkinson's disease and could offer a new target for treatment, scientists at Nanyang Technological University, Singapore (NTU Singapore) have found.

9 Apr 2026

Swapping passive screen time with mental activity may cut dementia risk

Research shows that mentally active sedentary behavior can reduce dementia risk, emphasizing the importance of daily cognitive engagement for brain health.

9 Apr 2026

UCF experts aim to find better ways to prevent domestic violence and empower survivors

Florida is turning to UCF experts to find better ways to prevent domestic violence and give survivors a stronger voice in the services they need.

8 Apr 2026

New method reveals how the genome is regulated and disrupted in diseases

Researchers at the University of Minnesota Medical School have developed a new method called PARTAGE that provides a clearer picture of how the genome is regulated and disrupted in diseases like cancer.

8 Apr 2026

Apparent drug overdose spike in 2025 driven by flawed modeling

Last June, several mainstream media outlets reported a surge in U.S. drug overdose deaths in early 2025 that was based on data from the U.S. Centers for Disease Control and Prevention (CDC).

8 Apr 2026

Stem cell study identifies universal checkpoint controlling cell identity

A study published in Cell Research advances a central idea in stem cell biology by identifying a checkpoint that controls the identity of many different types of stem cells across developmental stages.

8 Apr 2026

Self-employment linked to lower heart disease risks in Hispanic women

Self-employed Hispanic women report less high blood pressure, obesity, diabetes, poor health and binge drinking compared to Hispanic women working for salary or wages, new research suggests.

8 Apr 2026

Preconditioned skin cells enable faster and more effective wound healing

It is well known that students who prepare in advance perform better on exams. Now, it appears that the skin can do the same.

8 Apr 2026

Genetic overlap links psychiatric disorders with many physical ailments

For centuries, mental illness and physical disease have been viewed as two distinct categories, each with its own field of study, its own doctors, and its own menu of treatments.

8 Apr 2026

New steerable optical fiber reaches previously inaccessible larynx tumors

Worcester Polytechnic Institute (WPI) researchers have developed a flexible optical fiber that can be threaded through a medical endoscope and steered into the larynx to destroy hard-to-reach tumors on the vocal folds, an advance that could expand outpatient laser treatment options for patients whose only other choice might be surgery under general anesthesia.

8 Apr 2026

Long-term excess weight is a stronger predictor of cardiovascular risk

Obesity is a known risk factor for cardiovascular disease, but people's weights can shift over time, and little is known about the cumulative impact of excess weight.

8 Apr 2026

Insilico Medicine nominates AI-driven drug candidate for cancer, Cushing's syndrome and obesity

The NR3C1 (nuclear receptor subfamily 3 group C member 1) gene encodes the glucocorticoid receptor (GR), a nuclear receptor vital for maintaining physiological homeostasis, and inhibition of NR3C1 could increase the sensitivity of cancer cells to standard chemotherapy, particularly in ovarian cancer.

8 Apr 2026

New monoclonal antibody shows promise for preventing Lyme disease

A Phase I clinical trial of a human monoclonal antibody discovered and developed at UMass Chan Medical School for the prevention of Lyme disease in the U.S. was well tolerated and showed lasting serum concentrations in participants, according to data presented by Mark Klempner, MD, at the World Vaccine Congress 2026 in Washington D.C.

8 Apr 2026